“Biotech company Biocad has begun supplying the COVID-19 vaccine to the center.
Gamalea for large-scale vaccination against coronavirus in the country, "the Izvestia newspaper quotes a company representative.
According to CEO Dmitry Morozov, the decision to manufacture Sputnik V at Biocad facilities was made in early September.
He noted that more than 400 employees of the company are involved in vaccine projects.
Previously, the head of the Research Center for Epidemiology and Microbiology named after N.F.
Gamaleya of the Ministry of Health of Russia, Alexander Gintsburg, said that about 320 thousand doses of the Sputnik V coronavirus vaccine had been delivered to civilian circulation.
Singer and composer Pyotr Nalich, in an interview with NSN, suggested not to divide vaccines by country of production and ideology.